Skip to main content

Journal article Published 2021

pH-responsive polymersome-mediated delivery of doxorubicin into tumor sites enhances the therapeutic efficacy and reduces cardiotoxic effects

Authors

L.C. Albuquerque, V. Sincari, A. Jager, J. Kucka, J. Humajova, J. Pankrac, P. Paral, T. Heizer, O. Janouskova, I. Davidovich, Y. Talmon, P. Pouckova, P. Stepanek, L. Sefc, M. Hruby,
Show all 17 authors F.C. Giacomelli, A. Jager

Journal of Controlled Release : Official Journal of the Controlled Release Society 332, 529-538 (2021)

Cite this publication

ALBUQUERQUE, L., V. SINCARI, A. JAGER, J. KUCKA, J. HUMAJOVA, J. PANKRAC, P. PARAL, T. HEIZER, O. JANOUSKOVA, I. DAVIDOVICH, Y. TALMON, P. POUCKOVA, P. STEPANEK, L. SEFC, M. HRUBY, F. GIACOMELLI, A. JAGER: pH-responsive polymersome-mediated delivery of doxorubicin into tumor sites enhances the therapeutic efficacy and reduces cardiotoxic effects. Journal of Controlled Release : Official Journal of the Controlled Release Society. 2021, 332, 529-538, ISSN: 0168-3659, PMID: 33716094.

Details

ISSN
0168-3659